z-logo
Premium
Effect of 1‐aminocyclopropanecarboxylic acid on N‐methyl‐ d ‐aspartate‐stimulated [ 3 H]‐noradrenaline release in rat hippocampal synaptosomes
Author(s) -
Clos M.V.,
Sanz A. Garcia,
Trullas R.,
Badia A.
Publication year - 1996
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1111/j.1476-5381.1996.tb15484.x
Subject(s) - nmda receptor , glycine , chemistry , agonist , glycine receptor , partial agonist , hippocampal formation , pharmacology , receptor , biochemistry , endocrinology , amino acid , biology
1 The effect of 1‐aminocyclopropanecarboxylic acid (ACPC), a partial agonist at the glycine site of the N‐methyl‐ d ‐aspartate (NMDA) receptor complex that exhibits neuroprotective, anxiolytic and antidepressant‐like actions, was investigated in a functional assay for presynaptic NMDA receptors. 2 NMDA (100 μ m ) produced a 36% increase of tritium efflux above basal efflux in rat hippocampal synaptosomes preincubated with [ 3 H]‐noradrenaline ([ 3 H]‐NA), reflecting a release of tritiated noradrenaline. This effect was prevented by 10 μ m 7‐chlorokynurenic acid, an antagonist of the glycine site of the NMDA receptor. 3 Glycine enhanced the effect of NMDA with E max and EC 50 values of 84 ± 11% and 1.82 ± 0.04 μ m , respectively. ACPC potentiated the effect of NMDA on tritium overflow with a lower EC 50 (43 ± 6 nM) and a lower maximal effect (E max = 40 ± 9%) than glycine. Furthermore, ACPC (0.1 μ m ) shifted the EC 50 of glycine from 1.82 μ m to ≥ 3 mM. 4 These results show that ACPC can reduce the potentiation by glycine of NMDA‐evoked [ 3 H]‐NA release and hence, may act as an antagonist at the glycine site of presynaptic hippocampal NMDA receptors when the concentration of glycine is high.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here